Effectiveness of regdanvimab on mortality in COVID-19 infected patients on hemodialysis
Background Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (COVID-19), there are lack of effective and proven treatments for end-stage renal disease (ESRD). The present study aims to evaluate the effectiveness of regdanvimab on mortality in COVID...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Korean Society of Nephrology
2024-01-01
|
| Col·lecció: | Kidney Research and Clinical Practice |
| Matèries: | |
| Accés en línia: | http://krcp-ksn.org/upload/pdf/j-krcp-23-137.pdf |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|